Omega-3 index, obesity and insulin resistance in children

Int J Pediatr Obes. 2011 Jun;6(2-2):e532-9. doi: 10.3109/17477166.2010.549489. Epub 2011 Jan 12.

Abstract

Objectives: Recent studies in adults have suggested that the plasma level of omega-3 fatty acids may be associated with weight status and abdominal adiposity, limited studies exist in paediatric populations. The present study examined the relationship between the omega-3 index, weight status and insulin resistance in children.

Methods: School-age children between 5-12 years, classified as non-obese or obese on the basis of body mass index (BMI) z-scores, were examined. Fat intake was assessed using a parent reported 135-item semi-quantitative food frequency questionnaire. Erythrocyte fatty acid composition was determined using gas chromatography. The Omega-3 index (O3I) was calculated by adding eicosapentaenoic and docosahexaenoic acid % (weight/weight) values.

Results: Obese children had altered erythrocyte fatty acid composition unrelated to reported dietary intake. A greater proportion of obese (BMI z-score > 2.25) children (33%) had an omega-3 index of < 4.0 (high risk) compared with non-obese children (BMI z-score < 2.25) (17%). Simultaneously, the number of children with a higher omega-3 index (6.0-8.0 lower risk) was lower in the obese (13%) versus non-obese children (25%, respectively). A moderate, but statistically significant correlation was found between O3I and fasting insulin level (r = -0.3, P = 0.03) and with homeostatic model assessment (HOMA) scores (r = -0.3, P = 0.04). CONCLUSION; The observed association between the omega-3 index, weight status and insulin resistance in children highlights the importance of omega-3 fatty acids in the prevention of obesity-related chronic diseases in later life. The results presented merits confirmation in a larger sample of obese children.

Trial registration: ClinicalTrials.gov NCT00107692.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adiposity*
  • Analysis of Variance
  • Biomarkers / blood
  • Blood Glucose / analysis
  • Body Mass Index
  • Case-Control Studies
  • Chi-Square Distribution
  • Child
  • Child, Preschool
  • Chromatography, Gas
  • Diet
  • Docosahexaenoic Acids / administration & dosage
  • Docosahexaenoic Acids / blood*
  • Eicosapentaenoic Acid / administration & dosage
  • Eicosapentaenoic Acid / blood*
  • Erythrocytes / metabolism*
  • Female
  • Humans
  • Insulin / blood
  • Lipids / blood
  • Male
  • New South Wales
  • Obesity / blood
  • Obesity / diagnosis
  • Obesity / physiopathology
  • Obesity / prevention & control*
  • Risk Assessment
  • Risk Factors
  • Surveys and Questionnaires

Substances

  • Biomarkers
  • Blood Glucose
  • Insulin
  • Lipids
  • Docosahexaenoic Acids
  • Eicosapentaenoic Acid

Associated data

  • ClinicalTrials.gov/NCT00107692